TrialDiabetes, obesity & metabolism2021

Efficacy and safety of LY2963016 insulin glargine versus insulin glargine (Lantus) in Chinese adults with type 2 diabetes: A phase III, randomized, open-label, controlled trial.

Wenhuan Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.